|
|
|
| Home > For Researchers > Research Programmes > Overview |
|
| |
|
| |
The Humphrey Oei Institute of Cancer Research embodies our belief that patient-oriented research is the way to tackle cancer and that “Today’s research” will be “Tomorrow’s cure”.
Unless we have a good knowledge and understanding of the various types of cancers, the disease will continue to plague and haunt us and the generations to come. We need to find ways to prevent as well as to recognize early disease. Very often it is the early detection that saves lives.
Cancer accounts for approximately 30 per cent of all deaths in Singapore, making it the country’s top killer disease. Today, these figures would have increased if not for the efforts of the NCCS and other agencies in successfully gaining an upper hand in tackling the disease. Apart from creating a greater awareness through public education, the medical specialists have been successful in treating and curing more people through medical advances.
In our quest to achieve world-class research, NCCS has collaborated with reputable overseas institutions for a two-way exchange of know-how. Our research efforts have also been acclaimed by the medical fraternity overseas with publications in leading peer reviewed international journals like the Cell, Nature Cell Biology, New England Journal of Medicine, Lancet, Journal of Clinical Oncology, Oncogene and Cancer Research. In addition to the increasing number of high impact research publications, the Institute has attracted over $22.5 million in competitive research funding in FY 2006.
The work of our research staff brings with it the solemn promise of better research and evidence-based care to the patients we serve. It also brings with it our commitment and accountability to all who support our Institute’s research endeavours. I am fully confident that through the Humphrey Oei Institute of Cancer Research we would contribute to Singapore’s aim of developing world-class research in clinical and translational medicine for the good of mankind.
|
|
 |
| |
| |
|
